

Stellar Biotechnologies caters to the essential molecule demands of pharmaceutical and immunodiagnostic markets.
| Headquarter | 332 East Scott Street Port Hueneme Cbc Base, CA United States of America |
|---|---|
| Website | stellarbiotechnologies.com |
| Founding Date | 1999 |
| Tel | 8054882147 |
| Company Status | Public |
| Stock | SBOT |
Stellar Biotechnologies competitors include Biogen, MyoKardia, and Reata Pharmaceuticals. See below how Stellar Biotechnologies compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

Frank Oakes CEO / President
Frank Oakes serves as the CEO / President of Stellar Biotechnologies.

Gregory T. Baxter Ph.D. Executive Vice President of Corporate Development
Dr. Gregory T. Baxter, also known as Greg, Ph.D., has been an Executive Vice President of Corporate Development at...

Kathi Niffenegger CPA CFO, Corporate Secretary & Principal Accounting Officer
Ms. Kathi Niffenegger, CPA, has been a Corporate Secretary of Stellar Biotechnologies, Inc. since June 2013 and its...

Kathi Niffenegger Chief Financial Officer
Kathi Niffenegger serves as the Chief Financial Officer of Stellar Biotechnologies.

Mike Sampat Board of Directors
Mike Sampat serves as the Board of Directors of Stellar Biotechnologies.

No Recent Jobs found for Stellar Biotechnologies on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Stellar Biotechnologies address?
Stellar Biotechnologies location is at 332 East Scott Street
What is Stellar Biotechnologies revenue?
Stellar Biotechnologies revenue is $228k
Who are Stellar Biotechnologies competitors?
Stellar Biotechnologies main competitors are Biogen, MyoKardia, Reata Pharmaceuticals
Who is Stellar Biotechnologies leadership?
Gregory T. Baxter Ph.d., Kathi Niffenegger Cpa & Kathi Niffenegger are part of Stellar Biotechnologies leadership, Frank Oakes is the CEO